Travere Therapeutics (TVTX) Competitor Comparison
We are evaluating the key criteria listed to compare Travere Therapeutics (TVTX) against its competitors in the Biotechnology industry.
Market Capitalization
157 / 368Gross Profits
179 / 278Total Revenue
52 / 300EBITDA
298 / 337Free Cashflow
319 / 352Quick Ratio
193 / 357Earnings per Share
300 / 359Dividend yield
0 / 6Total Cash
46 / 358Performance 3 years
132 / 368Performance 5 years
99 / 368Performance 10 years
66 / 368Linearity 3 years
71 / 368Linearity 5 years
71 / 368Linearity 10 years
116 / 368Total Rank
43 / 368Dividend Rank
290 / 368Valuation Rank
133 / 368Piotroski Rank
340 / 368Muliplier Rank
100 / 368Market Capitalization - TVTX ranking 157 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.